Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLR | AZN | AMGN | GILD | BMY |
| Company | Allarity Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.2700 | 166.37 | 359.98 | 129.22 | 60.74 |
| High | 1.2880 | 169.49 | 371.84 | 131.07 | 62.05 |
| Low | 1.2150 | 166.04 | 359.21 | 127.61 | 60.45 |
| Latest | 1.2200 | 168.27 | 371.50 | 130.86 | 61.51 |
| Change | -0.0600 | -1.46 | +5.45 | +0.52 | +0.75 |
| % Change | -4.69% | -0.86% | +1.49% | +0.40% | +1.23% |
| Volume | 44,600 | 2,394,000 | 2,931,900 | 6,299,200 | 7,621,700 |
| 20-Day Average Volume | 115,640 | 2,742,080 | 2,280,080 | 7,478,140 | 11,195,440 |
| Previous Close | 1.2800 | 169.73 | 366.05 | 130.34 | 60.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2188 | 178.44 | 363.93 | 130.82 | 58.55 |
| 20-Day Raw Stochastic | 50.68% | 13.01% | 75.28% | 42.44% | 89.27% |
| 20-Day Relative Strength | 45.49 | 41.77 | 59.48 | 50.29 | 59.48 |
| Weighted Alpha | -31.22 | +4.80 | +22.78 | +9.56 | +28.95 |
| Today's Opinion | 24% Sell | 88% Sell | 72% Buy | 24% Sell | 72% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 72% Buy | 40% Sell | 72% Buy |
| Last Month's Opinion | 40% Buy | 56% Sell | 40% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.27% since 07/16/26 | -0.60% since 07/16/26 | -0.02% since 07/16/26 | -3.99% since 07/16/26 | +1.65% since 07/16/26 |
| Low | 1.1400 on 07/20/26 | 164.06 on 07/20/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 59.80 on 07/21/26 |
| High | 1.2880 on 07/23/26 | 170.89 on 07/22/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | -7.58% since 06/23/26 | -7.04% since 06/23/26 | +7.06% since 06/23/26 | +4.65% since 06/23/26 | +10.77% since 06/23/26 |
| Low | 1.0350 on 07/07/26 | 164.06 on 07/20/26 | 346.00 on 06/24/26 | 123.67 on 06/25/26 | 54.78 on 06/24/26 |
| High | 1.4000 on 07/02/26 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | -12.86% since 04/23/26 | -12.50% since 04/23/26 | +6.56% since 04/23/26 | -2.08% since 04/23/26 | +4.22% since 04/23/26 |
| Low | 1.0350 on 07/07/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.8395 on 05/27/26 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | +1.67% since 01/23/26 | -9.48% since 01/23/26 | +7.76% since 01/23/26 | -3.73% since 01/23/26 | +12.55% since 01/23/26 |
| Low | 0.7687 on 02/03/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.8395 on 05/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,366 | 263,235,600 | 197,560,096 | 161,826,224 | 124,076,232 |
| Shares Outstanding, K | 15,911 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 320,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -11,230,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 30,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -2,750,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.53 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 05/15/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/21/26 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.29 | 16.57 | 15.57 | 10.27 |